Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
2001 1
2003 1
2004 3
2005 3
2006 1
2010 1
2015 1
2016 1
2017 5
2018 3
2019 2
2020 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Management and treatment of lactose malabsorption.
Montalto M, Curigliano V, Santoro L, Vastola M, Cammarota G, Manna R, Gasbarrini A, Gasbarrini G. Montalto M, et al. Among authors: vastola m. World J Gastroenterol. 2006 Jan 14;12(2):187-91. doi: 10.3748/wjg.v12.i2.187. World J Gastroenterol. 2006. PMID: 16482616 Free PMC article. Review.
Active Surveillance for Low-Risk Prostate Cancer in Black Patients.
Butler S, Muralidhar V, Chavez J, Fullerton Z, Mahal A, Nezolosky M, Vastola M, Zhao SG, D'Amico AV, Dess RT, Feng FY, King MT, Mouw KW, Spratt DE, Trinh QD, Nguyen PL, Rebbeck TR, Mahal BA. Butler S, et al. Among authors: vastola m. N Engl J Med. 2019 May 23;380(21):2070-2072. doi: 10.1056/NEJMc1900333. N Engl J Med. 2019. PMID: 31116925 Free PMC article. No abstract available.
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran.
Di Stefano V, Fava A, Gentile L, Guaraldi P, Leonardi L, Poli L, Tagliapietra M, Vastola M, Fanara S, Ferrero B, Giorgi M, Perfetto F, Russo M, Russo D. Di Stefano V, et al. Among authors: vastola m. Pharmgenomics Pers Med. 2022 May 12;15:499-514. doi: 10.2147/PGPM.S359851. eCollection 2022. Pharmgenomics Pers Med. 2022. PMID: 35592550 Free PMC article.
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.
Yang DD, Mahal BA, Muralidhar V, Nezolosky MD, Vastola ME, Labe SA, Boldbaatar N, King MT, Martin NE, Orio PF 3rd, Beard CJ, Hoffman KE, Trinh QD, Spratt DE, Feng FY, Nguyen PL. Yang DD, et al. Among authors: vastola me. Eur Urol Focus. 2019 Jan;5(1):69-76. doi: 10.1016/j.euf.2017.05.011. Epub 2017 Jun 17. Eur Urol Focus. 2019. PMID: 28753811
25 results